Johnson & Johnson vs. Omeros Corporation
Johnson & Johnson (JNJ) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| JNJ | OMER | |
|---|---|---|
| Market Cap | $617.01 billion | $1.38 billion |
| Revenue (TTM) | $97.93 billion | — |
| Net Income (TTM) | $21.04 billion | — |
JNJ leads on 1 of 1 size & scale factors.
Valuation
| JNJ | OMER | |
|---|---|---|
| P/E Ratio | 29.34 | — |
| Price / Book | 7.26 | — |
| Price / Sales | 6.30 | — |
JNJ and OMER split the valuation factors evenly.
Profitability
| JNJ | OMER | |
|---|---|---|
| Net Margin | 21.48% | — |
| Return on Equity | 24.76% | — |
JNJ and OMER split the profitability factors evenly.
Dividend
| JNJ | OMER | |
|---|---|---|
| Dividend Yield | 2.12% | — |
| Payout Ratio | 62.18 | — |
JNJ and OMER split the dividend factors evenly.
Risk & Sentiment
| JNJ | OMER | |
|---|---|---|
| Short Interest | 0.67% | 9.61% |
JNJ leads on 1 of 1 risk & sentiment factors.
Dig deeper: JNJ overview, JNJ financials, OMER overview, OMER financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.